Health Minister Patty Hajdu said Friday that while there is still “a lot of back and forth on the data,” Health Canada is poised to make a decision on the Oxford University-AstraZeneca COVID-19 vaccine in the “near future.” She said, however, that decision on the Johnson & Johnson vaccine is “a little further out.”
- European regulator approves AstraZeneca’s coronavirus vaccine for adults
- AstraZeneca says reports of 8% coronavirus vaccine efficacy in seniors are ‘incorrect’